Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › DC › Washington › NPI 1508484569
Lab

Curative Labs INC.

Curative Labs INC. was paid $11.88M by Medicaid between Sep 2020 and Dec 2022, across 2 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 90% of everything it billed.

33Billing provider infoCURATIVE LABS INC.
WASHINGTON, DC 20002
33aNPI1508484569assigned 07/07/2020
28Total paid$11.88M
24GClaims412,495
24DCodes billed2
24AFirst – last monthSep 2020 – Dec 2022
Compared with peers

Next to other Clinical Medical Laboratory providers in District of Columbia

Rank by total paid#1 of 5
Median peer was paid$307K
This provider vs. median39×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Single-Code Concentration90% of spending on code U0003 with only 2 total codes billed. Highly concentrated billing profile.
Box 24A · Dates of service

Paid by month

$0$1.0M$2.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
202018,385$533K
2021250,133$5.39M
2022143,977$5.95M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 90% 252,202 142,408 $10.73M
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 9.6% 160,293 90,338 $1.14M

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialTURNER, FREDERICK (CHIEF EXECUTIVE OFFICER)
Same official

Other billing entities under TURNER, FREDERICK

Full network →
ProviderLocationPaid
Curative Labs INC.Round Rock, TX$20.31M
Shield Diagnostics Corp.San Jose, CA$27K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.